LEAVITT PARTNERS, LLC ON BEHALF OF SICKLE CELL DISEASE PARTNERSHIP

Lobbying client · Michigan · filed 2025 to 2026

consulting firm on behalf of multi-sector collaboration of health care stakeholders

$120,000 Reported spend

6 Filings counted

1 Firms hired

2 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (56967), not by name.

Firms hired 1

OGR $120,000 6 filings

Bills named in these filings 2

HR 1796
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act…

5 filings
HR 5178
Sickle Cell Disease Comprehensive Care Act

2 filings

Reported by year 2 years

2026 $40,000 2 filings
2025 $80,000 4 filings

Issues lobbied 1

Health Issues 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 1

HOUSE OF REPRESENTATIVES 6

Recent filings 6 total

Q2

OGR

2nd Quarter (Apr 1 - June 30) 2026 · House · $20,000 income · posted Jul 17, 2026

View → Q1

OGR

1st Quarter (Jan 1 - Mar 31) 2026 · House · $20,000 income · posted Apr 19, 2026

View → Q4

OGR

4th Quarter (Oct 1 - Dec 31) 2025 · House · $20,000 income · posted Jan 17, 2026

View → Q3

OGR

3rd Quarter (July 1 - Sep 30) 2025 · House · $20,000 income · posted Oct 19, 2025

View → Q2

OGR

2nd Quarter (Apr 1 - June 30) 2025 · House · $20,000 income · posted Jul 19, 2025

View → Q1

OGR

1st Quarter (Jan 1 - Mar 31) 2025 · House · $20,000 income · posted Apr 20, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.